Latest Ipsen Stories
International pharmaceutical company opens new headquarters in Ontario MISSISSAUGA, ON, April 15, 2015 /CNW/ - Ipsen Biopharmaceuticals Canada Inc., the Canadian affiliate of
-- Lexicon eligible for an additional $5 million in up-front and pre-commercial milestone payments for Canadian rights, plus royalties and sales milestones under original agreement --
-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct.
PARIS, June 30, 2014 /PRNewswire/ -- Pharnext SAS announced today that Ipsen has joined its Board of Directors. Highlights
BARCELONA, Spain, February 26, 2014 /PRNewswire/ -- Top pharmaceutical company selects Veeva Vault in enterprise initiative to
- an ornament or knob in the shape of a flower